Federal Case Summaries
Coverage since November 3, 1994

Federal

Uncategorized

Teva Pharmaceuticals v. Sandoz (Federal Circuit 2013) — Court Applies De Novo Review to All Claim Construction, Drawing Supreme Court Reversal

The Federal Circuit applied de novo review to all aspects of claim construction and affirmed the invalidity of Teva’s multiple sclerosis drug patents — a ruling the Supreme Court partially reversed in 2015, holding that underlying factual findings in claim construction must be reviewed for cle

Scroll to Top